In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants.

Lisanne Denneman Sophie Cohen Mieke H Godfried Elisabeth van Leeuwen Jeannine F B Nellen Taco W Kuijpers Dasja Pajkrt Atie van de Plas Colette Smit Anouschka M Weijsenfeld Henriette J Scherpbier Madeleine J Bunders

AIDS

aDepartment of Paediatric Hematology, Immunology and Infectious Diseases, Emma Children's Hospital, Academic Medical Centre (AMC), University of Amsterdam (UvA), Amsterdam bDepartment of Paediatrics, Amphia Hospital, Breda cDepartment of Internal Medicine dDepartment of Gynaecology and Obstetrics, AMC, UvA eHIV Monitoring Foundation fDepartment of Experimental Immunology, AMC, UvA, Amsterdam, The Netherlands. *Henriette J. Scherpbier and Madeleine J. Bunders contributed equally to the writing of this article.

Published: August 2016

Download full-text PDF	Source
http://dx.doi.org/10.1097/QAD.0000000000001156	DOI Listing

Publication Analysis

Top Keywords

in-utero exposure

exposure tenofovir

tenofovir associated

associated impaired

impaired fetal

fetal infant

infant growth

growth follow-up

follow-up studies

studies combination

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!